Medical Oncology

20 registered clinical trials studyying Medical Oncology — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	Geriatric and Oncological Evaluation With Technology for Holistic Healthcare Management for Older Multimorbid NCT05423808	Universitaire Ziekenhuizen KU Leuven	N/A
Recruiting	Improvement of Quality of Life by Cannabinoids in Oncologic Patients NCT06097533	University Hospital Schleswig-Holstein	Phase 2
Completed	Ezra Faster Scan Study NCT05385718	Ezra AI, Inc.	—
Recruiting	A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Im NCT05356182	State University of New York at Buffalo	N/A
Recruiting	A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Diet in Cancer Patients Receiv NCT05359848	State University of New York at Buffalo	N/A
Unknown	Onco-haematology Vigilance Card NCT04931329	University Hospital, Limoges	—
Completed	Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole NCT02824042	Bayer	Phase 1
Completed	Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing So NCT02639091	Bayer	Phase 1
Completed	Implementing an Evidence-based Computerized Decision Support System Linked to Electronic Health Records to Imp NCT02645357	Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS	N/A
Completed	Roniciclib (BAY 1000394) Drug-Drug Interaction (DDI) Study NCT02457351	Bayer	Phase 1
Terminated	Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous Docetaxel NCT02439346	Bayer	Phase 1
Completed	A Problem-Solving Intervention for Family Caregivers in Palliative Oncology NCT02427490	University of Missouri-Columbia	N/A
Terminated	Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblas NCT02368951	Bayer	Phase 1
Completed	Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel NCT02366949	Bayer	Phase 1
Unknown	The Effect of Pullsed Magnetic Field Induction on Improving the Forearm Tissue Muscle Performance NCT02327806	Tel-Aviv Sourasky Medical Center	N/A
Completed	COPANLISIB (BAY80-6946) Drug-drug Interaction and Cardiovascular Safety Study in Advanced Solid Tumor and Non- NCT02253420	Bayer	Phase 1
Terminated	Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel NCT02138812	Bayer	Phase 1
Completed	Transpulmonary Thermodilution Using an Implented Central Venous Access Port NCT02357953	Gustave Roussy, Cancer Campus, Grand Paris	—
Completed	Results From a Health System-wide Implementation of a Quality of Life Questionnaire NCT02906423	Allina Health System	—
Completed	A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express N NCT01409135	Astellas Pharma Inc	Phase 1